Skip to main content

Table 2 Persistence rate solifenacin after one year

From: Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin

 

Patients still using

Patients discontinued

Lost to FU

All patients

50 (40.7%)

61 (49.6%)

12 (9.7%)

Neurogenic OAB

23 (57.5%)

13 (32.5%)

4 (10%)

Idiopathic OAB

27 (32.5%)

48 (57.8%)

8 (9.7%)

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us